Effects of the SGLT2 inhibitor dapagliflozin in patients with type 2 diabetes and stages 3b-4 chronic kidney disease
Year: 2018
Type: article
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2786566584
